Progyny, Inc. Prepares for Its Upcoming Q3 Results
Progyny, Inc. (Nasdaq: PGNY), a leading company specializing in fertility and women's health benefits, is gearing up to share its financial results for the quarter that ended on September 30, 2024. This anticipated announcement will occur after the market closes on a Tuesday in mid-November.
Join the Conference Call for Financial Insights
To discuss these results in detail, Progyny will host a conference call. Interested parties can tune in at 4:45 PM Eastern Time, providing a valuable opportunity for investors and stakeholders to gain insights directly from company leaders.
Accessing the Call
Participants located in the United States may join the call by dialing 1.866.825.7331 and entering the passcode 265484. For those joining from other countries, the number is 1.973.413.6106, along with the same passcode. This is an excellent way to stay informed about Progyny's developments and strategic direction.
Audio Replay and Live Webcast
For those unable to attend the live call, an audio replay will be available for a limited time, enabling participants to catch up on crucial information shared during the discussion. The replay can be accessed from various phone numbers, ensuring easy availability for both U.S. and international participants.
Progyny's Vision and Commitment
Progyny is dedicated to transforming family building and women’s health benefits, collaborating with leading employers and health plans throughout the nation. Their mission is to create a world where everyone has the opportunity to achieve their family and health goals.
Innovative Benefits Solutions
The company's benefits package includes exceptional support, coaching, and education options, alongside cutting-edge digital tools that empower patients. Progyny prides itself on providing access to a distinguished network of fertility and women's health professionals who utilize the latest scientific advancements and technologies.
Achieving Optimal Outcomes
Progyny’s approach is not just about support; it is rooted in achieving optimal clinical outcomes that benefit employers, patients, and healthcare providers alike. By focusing on comprehensive and inclusive solutions, they strive to reduce healthcare costs while maximizing the effectiveness of treatments.
Recognitions and Growth
Headquartered in the vibrant city of New York, Progyny has received numerous accolades acknowledging its rapid growth and significant impact in the industry. Rankings as a TIME100 Most Influential Company and inclusion in the CNBC Disruptor 50 list are just a few of the honors that underscore their leadership in the field.
Commitment to Excellence
Aside from media recognition, Progyny has been celebrated in various lists, such as Modern Healthcare's Best Places to Work and Forbes' Best Employers. These recognitions reflect the company's commitment not just to its clients, but also to creating a positive workplace culture.
Contact Information for Investors and Media
For those wanting further details, Progyny encourages reaching out directly. Investors can connect with James Hart via email for insights and information regarding corporate affairs. Media inquiries can be directed to Alexis Ford, who handles press communications for the company.
Frequently Asked Questions
What is Progyny, Inc. known for?
Progyny, Inc. specializes in transformative fertility and women’s health benefits, working with numerous employers and health plans.
When will Progyny announce its Q3 2024 results?
The results for Q3 2024 are expected to be announced after the market closes on a Tuesday in mid-November.
How can I participate in the conference call?
You can dial 1.866.825.7331 for U.S. participants or 1.973.413.6106 for international attendees, using the passcode 265484.
Will there be a replay of the conference call?
Yes, an audio replay will be available after the call, ensuring you won’t miss any key insights.
How does Progyny support patients?
Progyny provides comprehensive support including coaching, education, and access to a top-tier network of specialists for fertility and women’s health.
